Ascendis Pharma A/S

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 16 20 14 8 5 2 11 13 7 8 51 267 364
Przychód Δ r/r 0.0% 31.0% -31.5% -41.9% -43.3% -66.8% 591.6% 26.4% -48.0% 11.9% 557.9% 421.2% 36.3%
Marża brutto 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 54.7% 76.3% 83.4% 87.8%
EBIT (mln) 2 5 -12 -42 -73 -112 -155 -227 -331 -452 -562 -456 -279
EBIT Δ r/r 0.0% 248.9% -327.1% 248.9% 74.3% 53.0% 38.7% 46.5% 45.8% 36.6% 24.4% -18.9% -38.8%
EBIT (%) 9.7% 25.9% -85.7% -515.2% -1583.2% -7290.3% -1462.6% -1695.1% -4755.1% -5808.6% -1097.9% -170.8% -76.7%
Koszty finansowe (mln) 0 0 0 0 0 0 0 1 2 4 50 44 66
EBITDA (mln) 2 6 -11 -41 -72 -110 -150 -217 -329 -424 -527 -438 -290
EBITDA(%) 12.4% 27.9% -82.1% -508.2% -1565.8% -7182.0% -1419.3% -1622.6% -4730.1% -5447.0% -1030.5% -164.3% -79.8%
Podatek (mln) 0 1 -1 -1 -0 -0 -0 -0 -0 -0 5 7 5
Zysk Netto (mln) 1 4 -10 -33 -69 -124 -130 -218 -419 -384 -583 -481 -378
Zysk netto Δ r/r 0.0% 226.3% -336.8% 240.9% 108.1% 80.9% 5.0% 67.6% 92.2% -8.4% 52.0% -17.4% -21.5%
Zysk netto (%) 8.0% 20.0% -69.1% -405.5% -1487.3% -8097.8% -1229.5% -1630.0% -6025.5% -4931.6% -1139.6% -180.5% -104.0%
EPS 0.12 0.38 -0.57 -1.39 -2.58 -3.68 -3.17 -4.69 -8.28 -7.0 -10.4 -8.55 -6.59
EPS (rozwodnione) 0.12 0.38 -0.57 -1.39 -2.58 -3.68 -3.17 -4.69 -8.28 -7.0 -10.4 -8.55 -6.59
Ilośc akcji (mln) 11 11 17 24 27 34 41 47 51 55 56 56 57
Ważona ilośc akcji (mln) 11 11 17 24 27 34 41 47 51 55 56 56 57
Waluta EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR